Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I dose-escalation clinical trial to evaluate the safety and immunogenicity of a multiclade, multivalent recombinant adenoviral vector HIV vaccine, VRC-HIVADV014-00-VP, in healthy, HIV-1 uninfected adult participants who have low titers of pre-existing Ad5 neutralizing antibodies
Description
HVTN 054 is a Phase I clinical trial to evaluate the safety and immunogenicity of VRC-HIVADV014-00-VP (rAd5).
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.